Seres Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. RH
5. NVDA
6. SPY
7. DOL:CN
8. RKLB
9. NDAQ
10. CRM

Go back to Seres Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates

Seres Therapeutics (MCRB) Reports Q3 EPS of $0.72

November 10, 2021 7:22 AM EST

Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of $0.72. Revenue for the quarter came in at $126.7M.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

... More